HEADER IMMUNE SYSTEM 31-JAN-01 1I1C TITLE NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A CAVEAT 1I1C FUC D 8 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: IG GAMMA-2A CHAIN C REGION; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: FC FRAGMENT; COMPND 5 SYNONYM: IGG2A; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: CHO-K1; SOURCE 9 EXPRESSION_SYSTEM_ORGAN: OVARY; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PBJ-5GS KEYWDS IGG, FC, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR W.L.MARTIN,A.P.WEST JR.,L.GAN,P.J.BJORKMAN REVDAT 7 09-AUG-23 1I1C 1 REMARK REVDAT 6 27-OCT-21 1I1C 1 SEQADV HETSYN REVDAT 5 29-JUL-20 1I1C 1 CAVEAT COMPND REMARK SEQADV REVDAT 5 2 1 HETNAM LINK SITE ATOM REVDAT 4 13-JUL-11 1I1C 1 VERSN REVDAT 3 24-FEB-09 1I1C 1 VERSN REVDAT 2 09-MAY-01 1I1C 1 JRNL REVDAT 1 14-FEB-01 1I1C 0 JRNL AUTH W.L.MARTIN,A.P.WEST JR.,L.GAN,P.J.BJORKMAN JRNL TITL CRYSTAL STRUCTURE AT 2.8 A OF AN FCRN/HETERODIMERIC FC JRNL TITL 2 COMPLEX: MECHANISM OF PH-DEPENDENT BINDING. JRNL REF MOL.CELL V. 7 867 2001 JRNL REFN ISSN 1097-2765 JRNL PMID 11336709 JRNL DOI 10.1016/S1097-2765(01)00230-1 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1496783.760 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 13471 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.241 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1375 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.80 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1227 REMARK 3 BIN R VALUE (WORKING SET) : 0.3250 REMARK 3 BIN FREE R VALUE : 0.4040 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 131 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.035 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3242 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 198 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.06000 REMARK 3 B22 (A**2) : 5.50000 REMARK 3 B33 (A**2) : 2.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.69000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM SIGMAA (A) : 0.40 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.51 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.940 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.690 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.360 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.930 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.650 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 26.82 REMARK 3 REMARK 3 NCS MODEL : CONSTRAINED REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1I1C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-FEB-01. REMARK 100 THE DEPOSITION ID IS D_1000012781. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-AUG-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13471 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 1.000 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : 0.05600 REMARK 200 FOR THE DATA SET : 13.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.00 REMARK 200 R MERGE FOR SHELL (I) : 0.29600 REMARK 200 R SYM FOR SHELL (I) : 0.26100 REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FC1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000 AMMONIUM ACETATE TRI-SODIUM REMARK 280 ACETATE DIHYDRATE, PH 6.4, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.68100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS THE GLYCOSYLATED HOMODIMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 50.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 223 REMARK 465 PRO A 224 REMARK 465 ARG A 225 REMARK 465 GLU A 226 REMARK 465 CYS A 227 REMARK 465 ASN A 228 REMARK 465 PRO A 229 REMARK 465 CYS A 230 REMARK 465 GLY A 231 REMARK 465 CYS A 232 REMARK 465 THR A 233 REMARK 465 GLY A 234 REMARK 465 SER A 235 REMARK 465 GLU A 236 REMARK 465 VAL A 237 REMARK 465 SER A 238 REMARK 465 SER A 444 REMARK 465 PRO A 445 REMARK 465 GLY A 446 REMARK 465 LYS A 447 REMARK 465 GLY A 448 REMARK 465 ILE A 449 REMARK 465 GLU A 450 REMARK 465 GLY A 451 REMARK 465 ARG A 452 REMARK 465 GLY A 453 REMARK 465 SER A 454 REMARK 465 SER A 455 REMARK 465 HIS A 456 REMARK 465 HIS A 457 REMARK 465 HIS A 458 REMARK 465 HIS A 459 REMARK 465 HIS A 460 REMARK 465 HIS A 461 REMARK 465 VAL B 223 REMARK 465 PRO B 224 REMARK 465 ARG B 225 REMARK 465 GLU B 226 REMARK 465 CYS B 227 REMARK 465 ASN B 228 REMARK 465 PRO B 229 REMARK 465 CYS B 230 REMARK 465 GLY B 231 REMARK 465 CYS B 232 REMARK 465 THR B 233 REMARK 465 GLY B 234 REMARK 465 SER B 235 REMARK 465 GLU B 236 REMARK 465 VAL B 237 REMARK 465 SER B 238 REMARK 465 SER B 444 REMARK 465 PRO B 445 REMARK 465 GLY B 446 REMARK 465 LYS B 447 REMARK 465 GLY B 448 REMARK 465 ILE B 449 REMARK 465 GLU B 450 REMARK 465 GLY B 451 REMARK 465 ARG B 452 REMARK 465 GLY B 453 REMARK 465 SER B 454 REMARK 465 SER B 455 REMARK 465 HIS B 456 REMARK 465 HIS B 457 REMARK 465 HIS B 458 REMARK 465 HIS B 459 REMARK 465 HIS B 460 REMARK 465 HIS B 461 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 340 N - CA - C ANGL. DEV. = 22.0 DEGREES REMARK 500 GLY A 341 N - CA - C ANGL. DEV. = 15.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 251 45.97 -96.40 REMARK 500 LEU A 255 -167.11 -49.36 REMARK 500 ASN A 297 32.68 -72.21 REMARK 500 SER A 298 14.10 50.64 REMARK 500 PRO A 339 -176.15 -49.87 REMARK 500 TYR A 373 139.04 -170.41 REMARK 500 LEU B 251 47.17 -96.95 REMARK 500 LEU B 255 -166.78 -48.81 REMARK 500 ASN B 297 32.78 -72.47 REMARK 500 SER B 298 13.85 50.54 REMARK 500 PRO B 339 -177.48 -51.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FC1 RELATED DB: PDB REMARK 900 HUMAN FC FRAGMENT OF IGG REMARK 900 RELATED ID: 1I1A RELATED DB: PDB REMARK 900 NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC DBREF 1I1C A 223 447 UNP P20760 GCA_RAT 98 322 DBREF 1I1C B 223 447 UNP P20760 GCA_RAT 98 322 SEQADV 1I1C GLY A 252 UNP P20760 THR 127 ENGINEERED MUTATION SEQADV 1I1C GLY A 253 UNP P20760 ILE 128 ENGINEERED MUTATION SEQADV 1I1C GLY A 254 UNP P20760 THR 129 ENGINEERED MUTATION SEQADV 1I1C GLU A 310 UNP P20760 HIS 185 ENGINEERED MUTATION SEQADV 1I1C GLU A 433 UNP P20760 HIS 308 ENGINEERED MUTATION SEQADV 1I1C GLU A 435 UNP P20760 HIS 310 ENGINEERED MUTATION SEQADV 1I1C GLY A 448 UNP P20760 CLONING ARTIFACT SEQADV 1I1C ILE A 449 UNP P20760 CLONING ARTIFACT SEQADV 1I1C GLU A 450 UNP P20760 CLONING ARTIFACT SEQADV 1I1C GLY A 451 UNP P20760 CLONING ARTIFACT SEQADV 1I1C ARG A 452 UNP P20760 CLONING ARTIFACT SEQADV 1I1C GLY A 453 UNP P20760 CLONING ARTIFACT SEQADV 1I1C SER A 454 UNP P20760 CLONING ARTIFACT SEQADV 1I1C SER A 455 UNP P20760 CLONING ARTIFACT SEQADV 1I1C HIS A 456 UNP P20760 CLONING ARTIFACT SEQADV 1I1C HIS A 457 UNP P20760 CLONING ARTIFACT SEQADV 1I1C HIS A 458 UNP P20760 CLONING ARTIFACT SEQADV 1I1C HIS A 459 UNP P20760 CLONING ARTIFACT SEQADV 1I1C HIS A 460 UNP P20760 CLONING ARTIFACT SEQADV 1I1C HIS A 461 UNP P20760 CLONING ARTIFACT SEQADV 1I1C GLY B 252 UNP P20760 THR 127 ENGINEERED MUTATION SEQADV 1I1C GLY B 253 UNP P20760 ILE 128 ENGINEERED MUTATION SEQADV 1I1C GLY B 254 UNP P20760 THR 129 ENGINEERED MUTATION SEQADV 1I1C GLU B 310 UNP P20760 HIS 185 ENGINEERED MUTATION SEQADV 1I1C GLU B 433 UNP P20760 HIS 308 ENGINEERED MUTATION SEQADV 1I1C GLU B 435 UNP P20760 HIS 310 ENGINEERED MUTATION SEQADV 1I1C GLY B 448 UNP P20760 CLONING ARTIFACT SEQADV 1I1C ILE B 449 UNP P20760 CLONING ARTIFACT SEQADV 1I1C GLU B 450 UNP P20760 CLONING ARTIFACT SEQADV 1I1C GLY B 451 UNP P20760 CLONING ARTIFACT SEQADV 1I1C ARG B 452 UNP P20760 CLONING ARTIFACT SEQADV 1I1C GLY B 453 UNP P20760 CLONING ARTIFACT SEQADV 1I1C SER B 454 UNP P20760 CLONING ARTIFACT SEQADV 1I1C SER B 455 UNP P20760 CLONING ARTIFACT SEQADV 1I1C HIS B 456 UNP P20760 CLONING ARTIFACT SEQADV 1I1C HIS B 457 UNP P20760 CLONING ARTIFACT SEQADV 1I1C HIS B 458 UNP P20760 CLONING ARTIFACT SEQADV 1I1C HIS B 459 UNP P20760 CLONING ARTIFACT SEQADV 1I1C HIS B 460 UNP P20760 CLONING ARTIFACT SEQADV 1I1C HIS B 461 UNP P20760 CLONING ARTIFACT SEQRES 1 A 239 VAL PRO ARG GLU CYS ASN PRO CYS GLY CYS THR GLY SER SEQRES 2 A 239 GLU VAL SER SER VAL PHE ILE PHE PRO PRO LYS THR LYS SEQRES 3 A 239 ASP VAL LEU GLY GLY GLY LEU THR PRO LYS VAL THR CYS SEQRES 4 A 239 VAL VAL VAL ASP ILE SER GLN ASN ASP PRO GLU VAL ARG SEQRES 5 A 239 PHE SER TRP PHE ILE ASP ASP VAL GLU VAL HIS THR ALA SEQRES 6 A 239 GLN THR HIS ALA PRO GLU LYS GLN SER ASN SER THR LEU SEQRES 7 A 239 ARG SER VAL SER GLU LEU PRO ILE VAL GLU ARG ASP TRP SEQRES 8 A 239 LEU ASN GLY LYS THR PHE LYS CYS LYS VAL ASN SER GLY SEQRES 9 A 239 ALA PHE PRO ALA PRO ILE GLU LYS SER ILE SER LYS PRO SEQRES 10 A 239 GLU GLY THR PRO ARG GLY PRO GLN VAL TYR THR MET ALA SEQRES 11 A 239 PRO PRO LYS GLU GLU MET THR GLN SER GLN VAL SER ILE SEQRES 12 A 239 THR CYS MET VAL LYS GLY PHE TYR PRO PRO ASP ILE TYR SEQRES 13 A 239 THR GLU TRP LYS MET ASN GLY GLN PRO GLN GLU ASN TYR SEQRES 14 A 239 LYS ASN THR PRO PRO THR MET ASP THR ASP GLY SER TYR SEQRES 15 A 239 PHE LEU TYR SER LYS LEU ASN VAL LYS LYS GLU THR TRP SEQRES 16 A 239 GLN GLN GLY ASN THR PHE THR CYS SER VAL LEU HIS GLU SEQRES 17 A 239 GLY LEU GLU ASN GLU HIS THR GLU LYS SER LEU SER HIS SEQRES 18 A 239 SER PRO GLY LYS GLY ILE GLU GLY ARG GLY SER SER HIS SEQRES 19 A 239 HIS HIS HIS HIS HIS SEQRES 1 B 239 VAL PRO ARG GLU CYS ASN PRO CYS GLY CYS THR GLY SER SEQRES 2 B 239 GLU VAL SER SER VAL PHE ILE PHE PRO PRO LYS THR LYS SEQRES 3 B 239 ASP VAL LEU GLY GLY GLY LEU THR PRO LYS VAL THR CYS SEQRES 4 B 239 VAL VAL VAL ASP ILE SER GLN ASN ASP PRO GLU VAL ARG SEQRES 5 B 239 PHE SER TRP PHE ILE ASP ASP VAL GLU VAL HIS THR ALA SEQRES 6 B 239 GLN THR HIS ALA PRO GLU LYS GLN SER ASN SER THR LEU SEQRES 7 B 239 ARG SER VAL SER GLU LEU PRO ILE VAL GLU ARG ASP TRP SEQRES 8 B 239 LEU ASN GLY LYS THR PHE LYS CYS LYS VAL ASN SER GLY SEQRES 9 B 239 ALA PHE PRO ALA PRO ILE GLU LYS SER ILE SER LYS PRO SEQRES 10 B 239 GLU GLY THR PRO ARG GLY PRO GLN VAL TYR THR MET ALA SEQRES 11 B 239 PRO PRO LYS GLU GLU MET THR GLN SER GLN VAL SER ILE SEQRES 12 B 239 THR CYS MET VAL LYS GLY PHE TYR PRO PRO ASP ILE TYR SEQRES 13 B 239 THR GLU TRP LYS MET ASN GLY GLN PRO GLN GLU ASN TYR SEQRES 14 B 239 LYS ASN THR PRO PRO THR MET ASP THR ASP GLY SER TYR SEQRES 15 B 239 PHE LEU TYR SER LYS LEU ASN VAL LYS LYS GLU THR TRP SEQRES 16 B 239 GLN GLN GLY ASN THR PHE THR CYS SER VAL LEU HIS GLU SEQRES 17 B 239 GLY LEU GLU ASN GLU HIS THR GLU LYS SER LEU SER HIS SEQRES 18 B 239 SER PRO GLY LYS GLY ILE GLU GLY ARG GLY SER SER HIS SEQRES 19 B 239 HIS HIS HIS HIS HIS MODRES 1I1C ASN B 297 ASN GLYCOSYLATION SITE MODRES 1I1C ASN A 297 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET NAG C 5 14 HET MAN C 6 11 HET NAG C 7 14 HET FUL C 8 10 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET MAN D 4 11 HET NAG D 5 14 HET MAN D 6 11 HET NAG D 7 14 HET FUC D 8 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUL BETA-L-FUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUL BETA-L-FUCOSE; 6-DEOXY-BETA-L-GALACTOPYRANOSE; L- HETSYN 2 FUL FUCOSE; FUCOSE; 6-DEOXY-BETA-L-GALACTOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 3 NAG 8(C8 H15 N O6) FORMUL 3 BMA 2(C6 H12 O6) FORMUL 3 MAN 4(C6 H12 O6) FORMUL 3 FUL C6 H12 O5 FORMUL 4 FUC C6 H12 O5 HELIX 1 1 LYS A 246 LEU A 251 1 6 HELIX 2 2 VAL A 309 ASN A 315 1 7 HELIX 3 3 PRO A 354 GLN A 360 5 7 HELIX 4 4 LYS A 414 GLN A 419 1 6 HELIX 5 5 LEU A 432 ASN A 434 5 3 HELIX 6 6 LYS B 246 LEU B 251 1 6 HELIX 7 7 VAL B 309 ASN B 315 1 7 HELIX 8 8 PRO B 354 GLN B 360 5 7 HELIX 9 9 LYS B 414 GLN B 419 1 6 HELIX 10 10 LEU B 432 ASN B 434 5 3 SHEET 1 A 4 VAL A 240 PHE A 243 0 SHEET 2 A 4 LYS A 258 ILE A 266 -1 O THR A 260 N PHE A 243 SHEET 3 A 4 LEU A 300 PRO A 307 -1 N LEU A 300 O ILE A 266 SHEET 4 A 4 GLN A 288 THR A 289 -1 O GLN A 288 N GLU A 305 SHEET 1 B 4 VAL A 240 PHE A 243 0 SHEET 2 B 4 LYS A 258 ILE A 266 -1 O THR A 260 N PHE A 243 SHEET 3 B 4 LEU A 300 PRO A 307 -1 N LEU A 300 O ILE A 266 SHEET 4 B 4 GLU A 293 LYS A 294 -1 N GLU A 293 O ARG A 301 SHEET 1 C 4 GLU A 283 VAL A 284 0 SHEET 2 C 4 ARG A 274 ILE A 279 -1 O TRP A 277 N VAL A 284 SHEET 3 C 4 PHE A 319 ASN A 324 -1 N LYS A 320 O PHE A 278 SHEET 4 C 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 D 4 GLN A 347 MET A 351 0 SHEET 2 D 4 GLN A 362 PHE A 372 -1 O THR A 366 N MET A 351 SHEET 3 D 4 TYR A 404 LYS A 413 -1 N TYR A 404 O PHE A 372 SHEET 4 D 4 TYR A 391 ASN A 393 -1 O LYS A 392 N LYS A 409 SHEET 1 E 4 GLN A 347 MET A 351 0 SHEET 2 E 4 GLN A 362 PHE A 372 -1 O THR A 366 N MET A 351 SHEET 3 E 4 TYR A 404 LYS A 413 -1 N TYR A 404 O PHE A 372 SHEET 4 E 4 THR A 397 MET A 398 -1 N THR A 397 O PHE A 405 SHEET 1 F 4 GLN A 386 PRO A 387 0 SHEET 2 F 4 TYR A 378 MET A 383 -1 N MET A 383 O GLN A 386 SHEET 3 F 4 PHE A 423 LEU A 428 -1 N THR A 424 O LYS A 382 SHEET 4 F 4 HIS A 436 LEU A 441 -1 O THR A 437 N VAL A 427 SHEET 1 G 4 VAL B 240 PHE B 243 0 SHEET 2 G 4 LYS B 258 ILE B 266 -1 O THR B 260 N PHE B 243 SHEET 3 G 4 LEU B 300 PRO B 307 -1 N LEU B 300 O ILE B 266 SHEET 4 G 4 GLN B 288 THR B 289 -1 O GLN B 288 N GLU B 305 SHEET 1 H 4 VAL B 240 PHE B 243 0 SHEET 2 H 4 LYS B 258 ILE B 266 -1 O THR B 260 N PHE B 243 SHEET 3 H 4 LEU B 300 PRO B 307 -1 N LEU B 300 O ILE B 266 SHEET 4 H 4 GLU B 293 LYS B 294 -1 N GLU B 293 O ARG B 301 SHEET 1 I 4 GLU B 283 VAL B 284 0 SHEET 2 I 4 ARG B 274 ILE B 279 -1 O TRP B 277 N VAL B 284 SHEET 3 I 4 PHE B 319 ASN B 324 -1 N LYS B 320 O PHE B 278 SHEET 4 I 4 ILE B 332 ILE B 336 -1 O ILE B 332 N VAL B 323 SHEET 1 J 4 GLN B 347 MET B 351 0 SHEET 2 J 4 GLN B 362 PHE B 372 -1 O THR B 366 N MET B 351 SHEET 3 J 4 TYR B 404 LYS B 413 -1 N TYR B 404 O PHE B 372 SHEET 4 J 4 TYR B 391 ASN B 393 -1 O LYS B 392 N LYS B 409 SHEET 1 K 4 GLN B 347 MET B 351 0 SHEET 2 K 4 GLN B 362 PHE B 372 -1 O THR B 366 N MET B 351 SHEET 3 K 4 TYR B 404 LYS B 413 -1 N TYR B 404 O PHE B 372 SHEET 4 K 4 THR B 397 MET B 398 -1 N THR B 397 O PHE B 405 SHEET 1 L 4 GLN B 386 PRO B 387 0 SHEET 2 L 4 TYR B 378 MET B 383 -1 O MET B 383 N GLN B 386 SHEET 3 L 4 PHE B 423 LEU B 428 -1 N THR B 424 O LYS B 382 SHEET 4 L 4 HIS B 436 LEU B 441 -1 O THR B 437 N VAL B 427 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.04 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.03 SSBOND 3 CYS B 261 CYS B 321 1555 1555 2.03 SSBOND 4 CYS B 367 CYS B 425 1555 1555 2.03 LINK ND2 ASN A 297 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN B 297 C1 NAG D 1 1555 1555 1.46 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 LINK O6 NAG C 1 C1 FUL C 8 1555 1555 1.40 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.38 LINK O3 BMA C 3 C1 MAN C 4 1555 1555 1.39 LINK O6 BMA C 3 C1 MAN C 6 1555 1555 1.40 LINK O2 MAN C 4 C1 NAG C 5 1555 1555 1.39 LINK O2 MAN C 6 C1 NAG C 7 1555 1555 1.39 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.39 LINK O6 NAG D 1 C1 FUC D 8 1555 1555 1.40 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.38 LINK O3 BMA D 3 C1 MAN D 4 1555 1555 1.39 LINK O6 BMA D 3 C1 MAN D 6 1555 1555 1.40 LINK O2 MAN D 4 C1 NAG D 5 1555 1555 1.38 LINK O2 MAN D 6 C1 NAG D 7 1555 1555 1.39 CISPEP 1 TYR A 373 PRO A 374 0 0.02 CISPEP 2 TYR B 373 PRO B 374 0 -0.27 CRYST1 42.503 73.362 82.157 90.00 102.74 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023528 0.000000 0.005319 0.00000 SCALE2 0.000000 0.013631 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012479 0.00000